Updated statement relating to media stories about a former staff member

27 Nov 2020, 6:35 p.m.

A spokesperson for Great Ormond Street Hospital said:

These charges relating to a former member of GOSH staff are awful.

It was upsetting to hear from court today that some of the charges relate to the hospital site. However, it is important to stress, as stated by the judge today, that children at GOSH were not being targeted.

We will continue to support the police as they progress the case but we know many people will have concerns and questions.

Due to the ongoing legal proceedings we are really limited in what we can say but we can confirm again that Paul Farrell was dismissed from the Trust.

Safeguarding is fundamental to the care we provide. We review our safeguarding policies regularly and they are in line with national best practice and we have a dedicated safeguarding team who are the point of contact for all concerns and referrals. All our staff are required to carry out safeguarding training appropriate to their role.

We urge anyone who has concerns about this case to call the helpline that we have set up with the NSPCC on 0800 101 996 or to email help@nspcc.org.uk. There's a page with more information on our helpline here.

Our former statement can be found here.

Chief Medical Officer takes up new role at Barts Health

Professor Sanjiv Sharma will be leaving Great Ormond Street Hospital (GOSH) to take up the new role of Group Chief Medical Officer for Barts Health NHS Trust.

Construction activity weekend of 16 and 17 November 2024

On Saturday and Sunday 16 and 17 November 2024 during the day, a crane will be on Great Ormond Street to remove materials from the roof of the frontage building and to lift equipment on to the roof.

GOSH pilots AI tool to give clinicians more quality-time with patients

Patients and clinicians at GOSH have been taking part in the first NHS trial of a bespoke healthcare AI assistant, TORTUS, to help increase face-to-face time during appointments.

New hope to prevent blindness in children with rare genetic disease

A new treatment that could prevent blindness in children with the CLN2 type Batten disease has been trialled by Clinicians at GOSH and University College London Great Ormond Street Institute of Child Health (UCL GOS ICH).